U.S. Markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
4.100.00 (0.00%)
At close: 4:00PM EDT
People also watch
NVAXHEBVICLARRYAGEN
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts8888
Avg. Estimate-0.18-0.17-0.73-0.76
Low Estimate-0.23-0.22-0.85-0.92
High Estimate-0.13-0.11-0.61-0.58
Year Ago EPS-0.16-0.06-0.75-0.73
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts8888
Avg. Estimate4.94M5.48M22.59M20.94M
Low EstimateN/AN/A12.5MN/A
High Estimate7.84M9.2M29.58M39.2M
Year Ago Sales7.76M8.98M26.35M22.59M
Sales Growth (year/est)-36.40%-39.00%-14.30%-7.30%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.24-0.23-0.19-0.19
EPS Actual-0.16-0.06-0.19-0.21
Difference0.080.170-0.02
Surprise %33.30%73.90%0.00%-10.50%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.18-0.17-0.73-0.76
7 Days Ago-0.17-0.17-0.72-0.76
30 Days Ago-0.16-0.2-0.73-0.75
60 Days Ago-0.16-0.2-0.73-0.75
90 Days Ago-0.19-0.19-0.73-0.72
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3432
Down Last 30 Days111N/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesBCRXIndustrySectorS&P 500
Current Qtr.-12.50%N/AN/A0.19
Next Qtr.-183.30%N/AN/A0.27
Current Year2.70%N/AN/A0.08
Next Year-4.10%N/AN/A0.11
Next 5 Years (per annum)19.90%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A